-
Ban on Negotiating Medicare drug prices under pressure Opens in a new window)
Negotiating Medicare drug prices is a linchpin of President Joe Biden's ambitious health care agenda. -
With D.C. Drug Pricing Talks Up In The Air, The 'Endgame' Could Still 'Have a Bite,' Analyst Says Opens in a new window)
With Democrats in Washington debating the specifics of the president's infrastructure program, the pharmaceutical industry may be able to squeak out a much-desired drug pricing win.Comments
-
B.C. to fund 'game changer' cystic fibrosis drug Trikafta Opens in a new window)
The B.C. government has also announced a new provincially co-ordinated model of care for cystic fibrosis patients.Comments
-
Winnipeg Family Urges Province to Cover the Cost of New Cystic Fibrosis Drug Opens in a new window)
'We might need to make a move if Manitoba can't make a decision quickly,' says mom of boy with cystic fibrosis.Comments
-
The American People Want Us TO ACT.
The vast majority of the American people want us to substantially lower prescription drug costs.Comments
-
Rapid COVID-19 Tests Increasingly Scarce, Pricey as Demand from Employers Jumps Opens in a new window)
Nearly a dozen state governments said they are grappling with shortages of rapid tests, which provide on-the-spot results within minutes and are crucial for COVID-19 surveillance programs.Comments
-
‘Pharma Bro’ Review: Behind the Smirk Opens in a new window)
This documentary grasps at straws trying to prove that the former pharmaceutical executive Martin Shkreli might not be as loathsome as his reputation suggests.Comments
-
Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What it Costs to Make Opens in a new window)
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense.Comments
-
Understand Your Drug Costs with Medicare.gov/plan-compare
You can estimate your drug costs at Medicare.gov/plan-compare.Comments
-
High-Expenditure Medicare Drugs Often Qualified for Orphan Drug Act incentives deSigned to Encourage the Development of Treatments for Rare Diseases
The Orphan Drug Act (ODA) provides financial incentives to encourage the development of drugs for rare diseases or conditions for which treatments might not be developed otherwise.Comments
-
Eli Lilly CEO: Drug Pricing Bill Would 'Fundamentally Restructure' Company
Eli Lilly CEO David Ricks joins CNBC's Meg Tirrell to discuss how a pending drug pricing bill would "fundamentally restructure" the company's business model.Comments
-
Aduhelm In Medicaid: States Must Cover, CMS Official Says Opens in a new window)
Medicaid’s pharmacy director says the Biogen Alzheimer’s drug is ‘currently a covered outpatient drug.Comments
-
Yukon Mother Calling on Territory to Cover 'Miracle' Cystic Fibrosis Drug Opens in a new window)
'I need their help to help me save my child's life'.Comments
-
Climate, Drug Prices, Child Care and Other Issues at Stake in Reconciliation Rift Opens in a new window)
It is a crucial day of negotiations on both sides of Pennsylvania Avenue in Washington, D.C., where Democrats are working around the clock to pass 2 significant bills — on infrastructure and major Democratic priorities in a reconciliation bill.Comments
-
DOJ Says Three Generic Drug Companies Resolve Price-Fixing Allegations Opens in a new window)
The Justice Department said these conspiracies allegedly resulted in higher drug prices for federal healthcare programs and beneficiaries according.Comments
Comments